Sanatela Medical

Sanatela Medical is a private biotechnology company based in Rochester, New York focused on commercializing biomaterial technologies derived from Wharton’s Jelly. Its lead platform, the Sanatela Matrix, is a decellularized 3D extracellular matrix scaffold designed to isolate and culture cancer stem cells, particularly leukemia stem cells, to support ex vivo drug screening and individualized treatment selection. The company positions the Matrix as both a cancer research and precision diagnostics tool and a broader regenerative medicine platform. Sanatela also describes future applications in wound care, burn treatment, and bone regeneration. The business appears to be at a preclinical and early commercialization-support stage, with research-grade product availability and plans for clinical trials and expanded access activity.